No one across the U.S. is consistently tracking climate-fueled deaths. One medical examiner has a new protocol on heat-deaths.
-
The incident is the latest eyebrow-raising bet on Polymarket, as allegations of rigging and manipulation continue to haunt the popular prediction market site.
-
AI companies are under growing scrutiny over the potential harms chatbots can pose amid investigations into how mass shooters allegedly sought advice from the tools.
-
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
-
NPR's Ailsa Chang talks with Amy Jaecker-Jones of the Natural History Museum of Los Angeles County about a worldwide community science project happening this weekend — the City Nature Challenge.
-
The cuts follow losses in two pivotal court cases and the company's push to invest in artificial intelligence.
-
Malaria hot spots have played a critical role in shaping where humans settled and either thrived or failed to thrive.
-
AI is threatening the availability of entry-level work.
-
A revolutionary new drug could prolong and improve the quality of life for those suffering from one of the world's deadliest cancers.
-
A new study looks at an unexpected force that played a critical role in shaping the lives of ancient humans.
-
Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which includes drugs like ketamine, Tylenol with codeine and anabolic steroids.